2021peer-reviewed1,239 citations
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, Emmanuel Rio, Éric François, Nathalie Mesgouez‐Nebout +4 more
The Lancet Oncology
Concepts
MedicineOxaliplatinCapecitabineFOLFIRINOXChemotherapyTotal mesorectal excisionChemoradiotherapyColorectal cancer